OTCMKTS:MAYNF Mayne Pharma Group - MAYNF Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Mayne Pharma Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. $2.55 0.00 (0.00%) (As of 01/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$2.55▼$2.5550-Day Range$0.15▼$3.9152-Week Range$0.12▼$0.29Volume50 shsAverage Volume2,325 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsHeadlinesShort Interest About Mayne Pharma Group (OTCMKTS:MAYNF) StockMayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.Read More Receive MAYNF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mayne Pharma Group and its competitors with MarketBeat's FREE daily newsletter. Email Address MAYNF Stock News HeadlinesDecember 7, 2022 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Lantheus (LNTH) and Mayne Pharma Group Limited (OtherMAYNF)December 5, 2022 | seekingalpha.comTherapeuticsMD enters agreements to license products to Mayne PharmaJanuary 30, 2023 | Porter & Company (Ad)Is This The End of Capitalism?EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…December 2, 2022 | finance.yahoo.comMayne Pharma Group Limited (ASX:MYX) Analysts Just Trimmed Their Revenue Forecasts By 19%November 9, 2022 | finance.yahoo.comMayne Pharma Group (ASX:MYX) investors are sitting on a loss of 54% if they invested five years agoSeptember 13, 2022 | fool.com.auIs the Mayne Pharma Group Ltd share price in the buy zone after today’s news?August 31, 2022 | finance.yahoo.comAnalysts Are More Bearish On Mayne Pharma Group Limited (ASX:MYX) Than They Used To BeAugust 16, 2022 | finance.yahoo.comDoes This Valuation Of Mayne Pharma Group Limited (ASX:MYX) Imply Investors Are Overpaying?January 30, 2023 | Porter & Company (Ad)Is This The End of Capitalism?EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…August 10, 2022 | finance.yahoo.comCatalent's New Acquisition will Expand High-Potent Capabilities, Oral Manufacturing Capacity: ReportJuly 29, 2022 | finance.yahoo.comMAYNE PHARMA AND GOODRX ANNOUNCE NEW INITIATIVE TO INCREASE AWARENESS OF NEXTSTELLIS® AND EXPAND ACCESS TO BIRTH CONTROLMay 1, 2022 | finance.yahoo.comMayne Pharma Group Limited (ASX:MYX) insider upped their holding by 120% earlier this yearFebruary 8, 2022 | finance.yahoo.comCould The Mayne Pharma Group Limited (ASX:MYX) Ownership Structure Tell Us Something Useful?December 5, 2021 | finance.yahoo.comMayne Pharma Group (ASX:MYX) investors are sitting on a loss of 82% if they invested five years agoOctober 19, 2021 | finance.yahoo.comMayne Pharma Group Limited's (ASX:MYX) Path To ProfitabilitySeptember 21, 2021 | finance.yahoo.comFDA Approves LEXETTE (R) for Adolescent Plaque PsoriasisAugust 2, 2021 | msn.comMayne Pharma (ASX:MYX) share price drops on class actionJune 26, 2021 | nasdaq.comMayne Pharma Group Limited (MAYNF)April 15, 2021 | msn.comMayne Pharma shares gain as its new birth control pill wins US approvalApril 15, 2021 | msn.comHere’s why the Mayne Pharma (ASX:MYX) share price is shooting 28% higherMarch 30, 2021 | au.finance.yahoo.com$1k into $3,760: What you'd have now if you bought some of 2015's top stocksMarch 26, 2021 | finance.yahoo.comIs There An Opportunity With Mayne Pharma Group Limited's (ASX:MYX) 38% Undervaluation?March 4, 2021 | finance.yahoo.comMayne Pharma launches another generic oral contraceptiveFebruary 23, 2021 | fool.com.auWhy the Mayne Pharma (ASX:MYX) share price is dropping 5% todaySee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive MAYNF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mayne Pharma Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Drug Manufacturers - Major Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:MAYNF CUSIPN/A CIKN/A Webwww.maynepharma.com Phone(188) 209-2666FaxN/AEmployees780Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Key ExecutivesMr. Shawn Patrick O'Brien B.ScCEO, MD & DirectorMr. Aaron GrayChief Financial OfficerMs. Kimberly Parker J.D.Exec. VP & Gen. CounselMr. Brant Schofield (Age 57)Exec. VP of Corp. Devel. Comp: $705.81kDr. Andrew O. Herdman Ph.D.VP of Group HRMr. Stefan J. Cross (Age 50)Pres of International Operations Comp: $403.54kMr. Daniel MooreExec. VP of Specialty Products & Patient SolutionsMr. Gerard G. Nahum M.D.Chief Medical OfficerMr. Hemanshu N. PandyaSr. VP & Head of Generic Product DivisionMr. Brenton WalterFinancial ControllerMore ExecutivesKey CompetitorsOtsukaOTCMKTS:OTSKYRocheOTCMKTS:RHHVFSanofiOTCMKTS:SNYNF[email protected] TechnologyOTCMKTS:LPTC1933 IndustriesOTCMKTS:TGIFFView All Competitors MAYNF Stock - Frequently Asked Questions How have MAYNF shares performed in 2023? Mayne Pharma Group's stock was trading at $2.50 on January 1st, 2023. Since then, MAYNF stock has increased by 2.0% and is now trading at $2.55. View the best growth stocks for 2023 here. Are investors shorting Mayne Pharma Group? Mayne Pharma Group saw a drop in short interest in January. As of January 15th, there was short interest totaling 825,200 shares, a drop of 39.9% from the December 31st total of 1,372,200 shares. Based on an average daily trading volume, of 2,000 shares, the days-to-cover ratio is currently 412.6 days. View Mayne Pharma Group's Short Interest. When did Mayne Pharma Group's stock split? Mayne Pharma Group shares reverse split before market open on Wednesday, January 18th 2023. The 1-20 reverse split was announced on Wednesday, January 18th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, January 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What is Mayne Pharma Group's stock symbol? Mayne Pharma Group trades on the OTCMKTS under the ticker symbol "MAYNF." How do I buy shares of Mayne Pharma Group? Shares of MAYNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Mayne Pharma Group's stock price today? One share of MAYNF stock can currently be purchased for approximately $2.55. How many employees does Mayne Pharma Group have? The company employs 780 workers across the globe. How can I contact Mayne Pharma Group? Mayne Pharma Group's mailing address is 1538 Main North Road, Salisbury, South Australia. The official website for the company is www.maynepharma.com. The company can be reached via phone at (188) 209-2666. This page (OTCMKTS:MAYNF) was last updated on 1/30/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.